These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10398105)

  • 81. Tyrosine phosphate in melanoma progression.
    McArdle L; Bergin O; Fallowfield ME; Dervan PA; Easty DJ
    Br J Dermatol; 2003 Aug; 149(2):289-95. PubMed ID: 12932234
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma.
    Rossi M; Tuck J; Kim OJ; Panova I; Symanowski JT; Mahalingam M; Riker AI; Alani RM; Ryu B
    Br J Dermatol; 2014 Aug; 171(2):403-8. PubMed ID: 24359286
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
    Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
    Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Detection of mRNA of Telomerase Protein in Benign Naevi and Melanomas Using RNAscope.
    Baltzarsen PB; Georgsen JB; Nielsen PS; Steiniche T; Stougaard M
    Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):36-41. PubMed ID: 30095463
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro.
    Shannan B; Seifert M; Leskov K; Boothman D; Pföhler C; Tilgen W; Reichrath J
    Anticancer Res; 2006; 26(4A):2707-16. PubMed ID: 16886681
    [TBL] [Abstract][Full Text] [Related]  

  • 86. IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.
    Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
    Mod Pathol; 2011 Jun; 24(6):801-9. PubMed ID: 21317876
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunohistochemical expression of retinoblastoma protein in cutaneous melanomas.
    Saenz-Santamaría MC; McNutt NS; Shea CR
    Br J Dermatol; 1995 Dec; 133(6):890-5. PubMed ID: 8547040
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of a novel gelsolin truncate in the vertical and metastatic phase malignant melanomas.
    Furukawa H; Fujita H; Kokubu I; Yamamoto Y; Sasaki S; Chodon T; Okubo Y; Sugihara T; Kuzumaki N
    Melanoma Res; 2002 Dec; 12(6):523-8. PubMed ID: 12459641
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The protein phosphatase 2A subunit Bgamma gene is identified to be differentially expressed in malignant melanomas by subtractive suppression hybridization.
    Deichmann M; Polychronidis M; Wacker J; Thome M; Näher H
    Melanoma Res; 2001 Dec; 11(6):577-85. PubMed ID: 11725204
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Genetic markers of melanoma].
    Tronov VA; Artamonov DN; Gorbacheva LB
    Genetika; 2010 Feb; 46(2):168-79. PubMed ID: 20297650
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies.
    Springall DR; Gu J; Cocchia D; Michetti F; Levene A; Levene MM; Marangos PJ; Bloom SR; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):331-43. PubMed ID: 6412442
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression.
    Bosserhoff AK
    Pigment Cell Res; 2005 Dec; 18(6):411-6. PubMed ID: 16280006
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma.
    van Kempen LC; Rijntjes J; Mamor-Cornelissen I; Vincent-Naulleau S; Gerritsen MJ; Ruiter DJ; van Dijk MC; Geffrotin C; van Muijen GN
    Int J Cancer; 2008 Mar; 122(5):1019-29. PubMed ID: 17957794
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparative histopathology of grey-horse-melanoma and human malignant melanoma.
    Seltenhammer MH; Heere-Ress E; Brandt S; Druml T; Jansen B; Pehamberger H; Niebauer GW
    Pigment Cell Res; 2004 Dec; 17(6):674-81. PubMed ID: 15541026
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Neuropilin-2 expression in cancer.
    Jubb AM; Sa SM; Ratti N; Strickland LA; Schmidt M; Callahan CA; Koeppen H
    Histopathology; 2012 Sep; 61(3):340-9. PubMed ID: 22384800
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma.
    Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F
    Br J Ophthalmol; 2011 Jun; 95(6):853-8. PubMed ID: 20956280
    [TBL] [Abstract][Full Text] [Related]  

  • 97. MIA--a new target protein for malignant melanoma therapy.
    Schmidt J; Riechers A; Bosserhoff AK
    Histol Histopathol; 2013 Apr; 28(4):421-6. PubMed ID: 23192727
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Expression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected].
    Gonin J; Carlotti A; Dietrich C; Audebourg A; Radenen-Bussière B; Caignard A; Avril MF; Vacher-Lavenu MC; Larousserie F; Devergne O
    PLoS One; 2013; 8(10):e75694. PubMed ID: 24130734
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Further evidence to support the melanocytic origin of MDA-MB-435.
    Ellison G; Klinowska T; Westwood RF; Docter E; French T; Fox JC
    Mol Pathol; 2002 Oct; 55(5):294-9. PubMed ID: 12354931
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Metastases in the hypophysis].
    Grabow D; Schwesinger G
    Zentralbl Neurochir; 1979; 40(1):29-34. PubMed ID: 484122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.